Educational Activities

Show Filters
Hide Filters
1-6 of 8 Activities
Title
Availability
Format
Credits
Course Opens
Buttons
Live
Symposium
1
09/27/2025 at 12:00 PM EDT

MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

In this CEC Oncology live, case-based symposium, expert faculty will discuss key characteristics of clinical presentation and disease advancement over a lifespan; review patient and caregiver education needs on the integration of MEK inhibitors in the management of NF1-associated PNs; and explore the role of nurses in comprehensive care plans, including disease monitoring, treatment personalization, toxicity management, and transitioning care of patients with NF1 across their lifespan.

1
09/27/2025 at 12:00 PM EDT

Sanita Burgic, MSN, APRN, AGNP-C

Sanita Burgic, MSN, APRN, AGNP-C

AeRang Kim, MD, PhD

AeRang Kim, MD, PhD

Amy Armstrong, MD

Amy Armstrong, MD

Live
Symposium
1
09/27/2025 at 12:00 PM EDT

Livestream: MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

In this CEC Oncology livestream, case-based symposium, expert faculty will discuss key characteristics of clinical presentation and disease advancement over a lifespan; review patient and caregiver education needs on the integration of MEK inhibitors in the management of NF1-associated PNs; and explore the role of nurses in comprehensive care plans, including disease monitoring, treatment personalization, toxicity management, and transitioning care of patients with NF1 across their lifespan.

1
09/27/2025 at 12:00 PM EDT

Sanita Burgic, MSN, APRN, AGNP-C

Sanita Burgic, MSN, APRN, AGNP-C

AeRang Kim, MD, PhD

AeRang Kim, MD, PhD

Amy Armstrong, MD

Amy Armstrong, MD

Live
Webcast
1
06/25/2025 at 6:30 PM EDT

Emerging Considerations for the Role of Biomarker-Driven Immunotherapy in Upper GI Cancers

In this CE Concepts live webcast, expert faculty will discuss utilizing biomarker tests to select therapeutic approaches for patients with upper GI cancers, implementing current guidelines and recent clinical evidence to individualize treatment, and integrating an MDT approach to deliver high-quality disease management.

1
06/25/2025 at 6:30 PM EDT

Samuel Cytryn, MD

Samuel Cytryn, MD

Leslie Swanson, ARNP, AOCNP

Leslie Swanson, ARNP, AOCNP

Samuel J. Klempner, MD, FASCO

Samuel J. Klempner, MD, FASCO

Moderator

Livestream: The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations

In this CE Concepts livestream symposium, expert faculty will assess neuro-oncologic features of NF1, including tumor types and neurological signs, to support early recognition and guide clinical decision-making; evaluate the use of mitogen-activated protein kinase inhibitors in the management of NF1-associated plexiform neurofibromas in pediatric and adult patients, including team-based care to manage adverse events; and develop evidence-based, interprofessional care plans that reflect current clinical standards and support individualized, longitudinal management.

1.5
09/14/2025 at 3:30 PM EDT

Carlos Romo, MD

Carlos Romo, MD

Miriam Bornhorst, MD

Miriam Bornhorst, MD

Angela Hirbe, MD, PhD

Angela Hirbe, MD, PhD

Moderator

Live
Grand Rounds
1
07/09/2025 at 12:00 PM EDT

Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches

In this CE Concepts Grand Rounds series, expert faculty will examine the evolving treatment landscape for advanced cervical cancer and discuss how they develop individualized treatment plans that apply current guideline recommendations, consider new treatment methods, and respect the unique needs of each patient.

1
07/09/2025 at 12:00 PM EDT

Bradley J. Monk, MD, FACS, FACOG

Bradley J. Monk, MD, FACS, FACOG

Live
Webcast
1
09/11/2025 at 5:15 PM EDT

Save the Date: Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies

In this CE Concepts livestream symposium, expert faculty will guide learners to identify features and challenges of early diagnosis and treatment of DTs, evaluate the use of novel targeted therapies, and implement evidence-based strategies to monitor and manage AEs associated with systemic therapies for DTs to improve patient safety and adherence.

1
09/11/2025 at 5:15 PM EDT